MGB Glomerular Disease Conference 2026

This is a live activity.

The 1-Day Glomerular Disease Conference will bring together clinicians and researchers to discuss recent advances in the understanding and management of glomerular diseases. The program will highlight emerging therapeutic strategies, clinical trial updates, and practical considerations for incorporating new agents into patient care. Sessions will include expert lectures, interactive case discussions, and debates. The conference aims to provide attendees with up-to-date, actionable insights that bridge science and clinical practice.

Target audience

This activity is intended for nephrologists and other health care professionals (physicians, physician assistants, nurses, nurse practitioners, and administrators) taking care of patients with autoimmune and rare kidney disease.

Learning objectives

Upon completion of this activity, participants will be able to:

1. Identify and interpret recent evidence-based clinical trials in glomerular diseases and their impact on treatment strategies.
2. Apply current data to the use of novel immunologic and complement-targeted therapies in clinical practice.
3. Apply personalized approaches and nuanced decision-making to optimize patient outcomes in glomerular disease management.

Registration instructions

Cancellation Policy:
Registrations cancelled on or before May 16, 2026 will be refunded, less a $15 administrative fee. Registrations cancelled after May 16, 2026 will not be refunded.

Contact Maxine Harney if you require assistance in cancelling your online registration.

Additional information

Faculty credentials

Conference Co-Directors

Harish Seethapathy, MD
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Massachusetts General Hospital

Ayman Al Jurdi, MD
Assistant Professor of Medicine, Harvard Medical School
Assistant in Medicine, Massachusetts General Hospital

Faculty

John Niles, MD
Associate Professor of Medicine, Harvard Medical School
Director, Vasculitis and Glomerulonephritis Center, Massachusetts General Hospital

Andrew Bomback, MD, MPH
Associate Professor of Medicine, Columbia University Irving Medical Center
Co-Director, Center for Glomerular Diseases, Columbia University Irving Medical Center

Michael Walsh, MD, PhD
Professor of Medicine, McMaster University
Scientist, Population Health Research Institute
Lead, Glomerulonephritis Registry and Research

Ali Poyan Mehr, MD
Founding President, GlomCon Foundation
Director of the Regional Glomerular Disease Program, Kaiser Permanente – Northern California

Gaia Coppock, MD
Assistant Professor of Clinical Medicine, Perelman School of Medicine
Director, Glomerular Disease Clinical Research Program and Lupus Nephritis Program, Hospital of the University of Pennsylvania

Purva Sharma, MD
Assistant Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Co-Director of the Glomerular Disease Center, Donald and Barbara Zucker School of Medicine at Northwell

David Mount, MD
Associate Professor of Medicine, Harvard Medical School
Clinical Director, Renal Division, Brigham and Women’s Hospital

Andrew Lundquist, MD, PhD
Assistant Professor of Medicine, Harvard Medical School
Associate Physician, Massachusetts General Hospital
Co-Director of Renal Genetics, Mass General Brigham

Meghan Sise, MD, MS
Associate Professor of Medicine, Harvard Medical School
Director, Onco-Nephrology Program, Massachusetts General Hospital

Orhan Efe, MD
Assistant Professor of Medicine, Harvard Medical School
Assistant in Medicine, Massachusetts General Hospital

Ashima Chaddha, MD
Clinical and Research Fellow, Mass General Brigham Vasculitis and Glomerulonephritis Center

Ana Onuchic-Whitford, MD
Assistant Professor of Medicine, Harvard Medical School
Co-Director of Renal Genetics, Mass General Brigham

Accreditation

In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statements

AMA PRA Category 1 Credits^TM
Mass General Brigham designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC RECOGNITION STATEMENT

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Program

Please join us on Friday, May 29th, 2026 for pre-conference events:

• 4:00-5:15pm Patient Forum (in partnership with the IgAN Foundation)
• 6:00-7:00pm Welcome Reception

Saturday, May 30, 2026